Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

Decipher Prostate Metastatic Genomic Classifier is now available for patients with metastatic prostate cancer.

Sharing his experience at the launch of MenCan, an initiative of Urologic Oncology Disease Management Group (URO DMG), a unit ...

PRO, but as the rules are new for January 2025, the exact coverage details, including out-of-pocket costs, are unclear. Read more.

Prostate Cancer and Prostatic Diseases covers all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. The journal also ...

Alexander Kenigsberg, MD, discusses a new nonsurgical, robotic-focused ultrasound procedure for prostate cancer.

Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...

Dr. Bruce Montgomery, a UW Medicine oncologist, hopes that patients won't see these numbers and just throw up their hands in fear or resignation.

Prostate cancer has distinct genetic properties in different groups of men that could be targeted to improve patient outcomes, new research suggests.

But a study has now revealed that for men, ejaculating regularly could be effective in preventing prostate cancer. The ...

A newly expanded prostate cancer drug could bring new hope to patients with a common form of the disease. Novartis, a Switzerland-based pharmaceutical company, announced on March 28 that the U.S ...